共 40 条
[1]
[Anonymous], 1993, J ICRU
[3]
Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2006, 66 (01)
:126-134
[4]
Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2005, 61 (02)
:318-328
[7]
Significance of plasma transforming growth factor-β levels in radiotherapy for non-small-cell lung cancer
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2004, 58 (05)
:1378-1387
[8]
Hi-chart: A phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2008, 71 (01)
:132-138
[10]
Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
1999, 45 (02)
:323-329